Clinical Trial Update: The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing persistence of autoantibody neutralization by BC 007 in patients with chronic heart failure and beta1-adrenergic receptor autoant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy Dilated
• Heart Failure

Drugs mentioned

• BC 007 (BC-007)

Snippet

Sponsor: Berlin Cures GmbH | Conditions: Cardiomyopathy, Dilated, Heart Failure | Phase 2 | Status: COMPLETED